Acute exposure to apolipoprotein A1 inhibits macrophage chemotaxis in vitro and monocyte recruitment in vivo

  1. Asif J Iqbal
  2. Tessa J Barrett
  3. Lewis Taylor
  4. Eileen McNeill
  5. Arun Manmadhan
  6. Carlota Recio
  7. Alfredo Carmineri
  8. Maximillian H Brodermann
  9. Gemma E White
  10. Dianne Cooper
  11. Joseph A DiDonato
  12. Stanley L Hazen
  13. Keith M Channon
  14. David R Greaves  Is a corresponding author
  15. Edward A Fisher  Is a corresponding author
  1. University of Oxford, United Kingdom
  2. NYU School of Medicine, United States
  3. Queen Mary University of London, United Kingdom
  4. Lerner Research Institute of the Cleveland Clinic, United States
  5. University of Oxford, United States

Abstract

Apolipoprotein A1 (apoA1) is the major protein component of high-density lipoprotein (HDL) and has well documented anti-inflammatory properties. To better understand the cellular and molecular basis of the anti-inflammatory actions of apoA1, we explored the effect of acute human apoA1 exposure on the migratory capacity of monocyte-derived cells in vitro and in vivo. Acute (20-60 min) apoA1 treatment induced a substantial (50-90%) reduction in macrophage chemotaxis to a range of chemoattractants. This acute treatment was anti-inflammatory in vivo as shown by pre-treatment of monocytes prior to adoptive transfer into an on-going murine peritonitis model. We find that apoA1 rapidly disrupts membrane lipid rafts, and as a consequence, dampens the PI3K/Akt signalling pathway that coordinates reorganization of the actin cytoskeleton and cell migration. Our data strengthen the evidence base for therapeutic apoA1 infusions in situations where reduced monocyte recruitment to sites of inflammation could have beneficial outcomes.

Article and author information

Author details

  1. Asif J Iqbal

    Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3224-3651
  2. Tessa J Barrett

    Division of Cardiology, NYU School of Medicine, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Lewis Taylor

    Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4622-9890
  4. Eileen McNeill

    Division of Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Arun Manmadhan

    Division of Cardiology, NYU School of Medicine, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Carlota Recio

    Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Alfredo Carmineri

    Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Maximillian H Brodermann

    Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Gemma E White

    Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Dianne Cooper

    William Harvey Research Institute, Queen Mary University of London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Joseph A DiDonato

    Department of Cellular and Molecular Medicine, Lerner Research Institute of the Cleveland Clinic, Cleavland, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Stanley L Hazen

    Department of Cellular and Molecular Medicine, Lerner Research Institute of the Cleveland Clinic, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Keith M Channon

    Division of Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  14. David R Greaves

    Sir William Dunn School of Pathology, University of Oxford, Oxford, United States
    For correspondence
    david.greaves@path.ox.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
  15. Edward A Fisher

    Division of Cardiology, NYU School of Medicine, New York, United States
    For correspondence
    Edward.Fisher@nyumc.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9802-143X

Funding

British Heart Foundation (RG/10/15/28578, PG/10/6028496, RG/15/10/31485)

  • Asif J Iqbal
  • Eileen McNeill
  • Keith M Channon
  • David R Greaves

Royal Society (IE120747)

  • David R Greaves
  • Edward A Fisher

National Institutes of Health (HL098055, DK095684)

  • Edward A Fisher

BHF Centre of Research Excellence, Oxford (RE/08/004/23915)

  • Asif J Iqbal
  • David R Greaves

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: UK animal studies were conducted with ethical approval from the Dunn School of Pathology Local Ethical Review Committee and in accordance with the UK Home Office regulations (Guidance on the Operation of Animals, Scientific Procedures Act, 1986). All USA animal experiments were carried out according to the guidelines of the National Institutes of Health and approved by the New York University Institutional Animal Care and Use Committee (Protocol 102090)

Human subjects: Human blood from anonymous healthy donors was obtained in the form of leukocyte cones from the NHS Blood and Transplant service. Leukocyte cones contain waste leukocytes isolated from individuals donating platelets via apharesis, and consist of a small volume (~10ml) of packed leukocytes with few red blood cells or platelets.

Copyright

© 2016, Iqbal et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,543
    views
  • 551
    downloads
  • 52
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Asif J Iqbal
  2. Tessa J Barrett
  3. Lewis Taylor
  4. Eileen McNeill
  5. Arun Manmadhan
  6. Carlota Recio
  7. Alfredo Carmineri
  8. Maximillian H Brodermann
  9. Gemma E White
  10. Dianne Cooper
  11. Joseph A DiDonato
  12. Stanley L Hazen
  13. Keith M Channon
  14. David R Greaves
  15. Edward A Fisher
(2016)
Acute exposure to apolipoprotein A1 inhibits macrophage chemotaxis in vitro and monocyte recruitment in vivo
eLife 5:e15190.
https://doi.org/10.7554/eLife.15190

Share this article

https://doi.org/10.7554/eLife.15190

Further reading

    1. Cell Biology
    2. Neuroscience
    Qi Jia, Drew Young ... Derek Sieburth
    Research Article

    The gut-brain axis mediates bidirectional signaling between the intestine and the nervous system and is critical for organism-wide homeostasis. Here, we report the identification of a peptidergic endocrine circuit in which bidirectional signaling between neurons and the intestine potentiates the activation of the antioxidant response in Caenorhabditis elegans in the intestine. We identify an FMRF-amide-like peptide, FLP-2, whose release from the intestine is necessary and sufficient to activate the intestinal oxidative stress response by promoting the release of the antioxidant FLP-1 neuropeptide from neurons. FLP-2 secretion from the intestine is positively regulated by endogenous hydrogen peroxide (H2O2) produced in the mitochondrial matrix by sod-3/superoxide dismutase, and is negatively regulated by prdx-2/peroxiredoxin, which depletes H2O2 in both the mitochondria and cytosol. H2O2 promotes FLP-2 secretion through the DAG and calcium-dependent protein kinase C family member pkc-2 and by the SNAP25 family member aex-4 in the intestine. Together, our data demonstrate a role for intestinal H2O2 in promoting inter-tissue antioxidant signaling through regulated neuropeptide-like protein exocytosis in a gut-brain axis to activate the oxidative stress response.

    1. Cell Biology
    2. Microbiology and Infectious Disease
    Erick E Arroyo-Pérez, John C Hook ... Simon Ringgaard
    Research Article

    The coordination of cell cycle progression and flagellar synthesis is a complex process in motile bacteria. In γ-proteobacteria, the localization of the flagellum to the cell pole is mediated by the SRP-type GTPase FlhF. However, the mechanism of action of FlhF, and its relationship with the cell pole landmark protein HubP remain unclear. In this study, we discovered a novel protein called FipA that is required for normal FlhF activity and function in polar flagellar synthesis. We demonstrated that membrane-localized FipA interacts with FlhF and is required for normal flagellar synthesis in Vibrio parahaemolyticus, Pseudomonas putida, and Shewanella putrefaciens, and it does so independently of the polar localization mediated by HubP. FipA exhibits a dynamic localization pattern and is present at the designated pole before flagellar synthesis begins, suggesting its role in licensing flagellar formation. This discovery provides insight into a new pathway for regulating flagellum synthesis and coordinating cellular organization in bacteria that rely on polar flagellation and FlhF-dependent localization.